Cogent Biosciences, Inc. (COGT)

CIK 1622229 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cogent Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Sep 2, 20268-K0001193125-26-380194
Aug 31, 202640001193125-26-377001
Aug 27, 20261440001950047-26-008754
Aug 13, 2026SCHEDULE 13G/A0001193805-26-001082
Aug 10, 202610-Q0001193125-26-342393
Aug 10, 20268-K0001193125-26-341315
Aug 10, 2026424B50001193125-26-342683
Aug 10, 20268-K0001193125-26-342695
Jul 31, 2026SCHEDULE 13G0002100119-26-001323
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002235
Jul 6, 202640001193125-26-296249
Jun 11, 202640001193125-26-267663
Jun 11, 202640001193125-26-267667
Jun 11, 202640001193125-26-267670
Jun 11, 202640001193125-26-267665
Jun 11, 20268-K0001193125-26-267566
Jun 11, 202640001193125-26-267662
Jun 11, 202640001193125-26-267666
May 21, 202640001193125-26-234578
May 14, 2026SCHEDULE 13G/A0001193805-26-000609
May 5, 20268-K0001193125-26-205124
May 5, 202610-Q0001193125-26-205170
Apr 23, 2026ARS0001193125-26-173857
Apr 23, 2026DEFA14A0001193125-26-173848
Apr 23, 2026DEF 14A0001193125-26-173834